摘要
The B-cell depletion agent rituximab (RTX) is used in lymphoma and rheumatoid arthritis (RA), and there have been several case reports of an RTX-induced reactivation of hepatitis C virus in patients with lymphoma. However, there have been no papers detailing hepatitis C virus reactivation after RTX therapy in a patient with RA. Here we report a case of RTX-induced hepatitis C virus reactivation in a patient with RA. Physicians should be aware that a close follow-up of liver function and viral load is mandatory after RTX therapy in patients with RA and concomitant hepatitis C.
| 原文 | 英語 |
|---|---|
| 頁(從 - 到) | 65-67 |
| 頁數 | 3 |
| 期刊 | Journal of Microbiology, Immunology and Infection |
| 卷 | 46 |
| 發行號 | 1 |
| DOIs | |
| 出版狀態 | 已出版 - 02 2013 |
| 對外發佈 | 是 |
UN SDG
此研究成果有助於以下永續發展目標
-
SDG3 健康與福祉
指紋
深入研究「Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver